about
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisInfiltrative CardiomyopathiesAG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinBiomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic reviewEvolving landscape in the management of transthyretin amyloidosis2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theTetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin TetramerTransthyretin Cardiac Amyloidosis in Older Americans.Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.Novel drugs targeting transthyretin amyloidosis.Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.Cooperative stabilization of transthyretin by clusterin and diflunisal.Cardiac amyloidosis in a heart transplant patient - A case report and retrospective analysis of amyloidosis evolution.IgG Conformer's Binding to Amyloidogenic Aggregates.Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its TreatmentSubstoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.Transthyretin Cardiac Amyloidosis in Black AmericansNovel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretinPreclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical centerInvestigational drugs targeting cardiac fibrosis.Liver transplantation in transthyretin amyloidosis: issues and challenges.Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.The transthyretin amyloidoses: advances in therapy.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.Advances in proteomic study of cardiac amyloidosis: progress and potential.Current and future treatment of amyloid diseases.Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.Recent advances in the noninvasive strategies of cardiac amyloidosis.Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease.Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function.
P2860
Q26782089-E2DDFA89-9E45-441A-A432-700E84B0565AQ26798533-5ED91D9D-6FCB-4AA0-9AF4-9C7DAAFB394AQ27678369-6EC0FC3F-E91E-4B2E-AF88-EB81D418E446Q28071491-331628B8-E3BF-4238-B787-3C64DA2B47BBQ28086773-009C8B9A-0741-4C64-A486-F1119A5C9AD5Q28087002-4C9EDC67-1834-40BD-B851-C2164FACE379Q28551432-A0C56B33-41F3-4361-897C-905633B53F07Q30244227-9461ACDD-0916-42A6-8FC0-291216ABF9E4Q33168881-B65593FA-AEEE-4055-AA7A-BE6E267DF047Q34400138-1BD23615-EF18-415D-BECF-E3D20442FB3AQ34487487-18F3E509-296E-450E-B1F4-C257FBFE243EQ34838524-4F9379BD-6A18-41B6-8DE7-8E2A99CA83CFQ35001154-0208D088-6B51-4F60-BAE1-89CC0B64D5C0Q35066592-3F310C0B-2A0D-4B08-AB49-9C97884AE940Q35772596-2ECF56B6-053A-49F1-B9AB-DA0E76DD1AD9Q35834448-5E259790-C4CD-4614-8217-8A5E948F401CQ35850786-842C8637-63A8-4F1D-B317-BD58B3BFBD38Q35949385-CA351929-EE1D-4253-AB21-C16D6BC40375Q36151383-76DFD505-9106-4094-964C-2E67857A352EQ36845920-66C1C300-93AB-4905-BAA8-D885B1F1746EQ36921392-4E56E23A-0C6E-4C04-9F8E-4D743E5228C3Q36981504-1744CFB3-FB72-4FCF-9A37-F40831BCEE26Q36981555-401C05D4-1487-4DCA-A984-9C2497B8F3C8Q37190740-A8BBD789-D2E4-40FC-B411-1827ABE6F875Q38161896-3F98F967-87D0-4E4A-9518-598298B02A2EQ38284506-097B54EB-8C55-4302-BBAD-8BBA66DE8A18Q38380856-28A8E16B-6DFD-41A9-A72E-E09A0ED84BEFQ38517905-577F1847-4876-41C3-BFF8-255BBC51ECF4Q38663987-6503EE27-2208-4468-A9EB-5EB6A0D676E0Q38807777-6BA8110B-FFAD-4193-B031-EF06EE0B364AQ38809423-87D2B6E5-355C-4A3D-9A6F-6E6301161680Q38831388-FD382758-9937-4CE4-B638-9118EDB0F8D9Q38871578-367D6BB8-CB3F-493C-B9E5-EECD2F88B547Q38935425-C4EF46D2-CAC5-407C-BB9E-7A1B6A323ABAQ38986995-A02E72C9-FF5C-408C-85E2-4FB05A1A0763Q39169812-43C33499-D739-43C2-9530-E359F75ACE72Q39178504-9850FE38-1809-4EA8-A036-D6270DEB682CQ39298962-E959215C-333F-44FE-A2FA-2F47963392FAQ40924968-D55FF28F-8220-4A28-A93B-AE9C195E7B2DQ40963422-BAB6C913-674B-4899-A353-FF7443C08DC6
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Transthyretin (TTR) cardiac amyloidosis.
@ast
Transthyretin (TTR) cardiac amyloidosis.
@en
type
label
Transthyretin (TTR) cardiac amyloidosis.
@ast
Transthyretin (TTR) cardiac amyloidosis.
@en
prefLabel
Transthyretin (TTR) cardiac amyloidosis.
@ast
Transthyretin (TTR) cardiac amyloidosis.
@en
P2860
P1433
P1476
Transthyretin (TTR) cardiac amyloidosis.
@en
P2093
Frederick L Ruberg
John L Berk
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.078915
P407
P577
2012-09-01T00:00:00Z